1
|
A review on various analytical methods for determination of anthracyclines and their metabolites as anti–cancer chemotherapy drugs in different matrices over the last four decades. Trends Analyt Chem 2020. [DOI: 10.1016/j.trac.2020.115991] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
2
|
Sedyakina NE, Krivoshchepov AF, Zasypko AY, Demchenko AG, Rozofarov AL, Kuryakov VN, Feldman NB, Lutsenko SV. Formulation, drug release features and in vitro cytotoxic evaluation of nonionic mixed surfactant stabilized water-in-oil microemulsion loaded with doxorubicin. MENDELEEV COMMUNICATIONS 2019. [DOI: 10.1016/j.mencom.2019.05.027] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
3
|
Chung SW, Cho YS, Choi JU, Kim HR, Won TH, Kim SY, Byun Y. Highly potent monomethyl auristatin E prodrug activated by caspase-3 for the chemoradiotherapy of triple-negative breast cancer. Biomaterials 2018; 192:109-117. [PMID: 30447398 DOI: 10.1016/j.biomaterials.2018.11.001] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2018] [Revised: 10/29/2018] [Accepted: 11/01/2018] [Indexed: 12/20/2022]
Abstract
Despite the emergence of advanced therapeutics such as targeted therapy and immunotherapy in the modern oncology, cytotoxic chemotherapy still remains as the first-line treatment option in a wide range of cancers attributing to its potency. Many endeavors have been made to overcome the toxicity issues of cytotoxic chemotherapy by improving the specific delivery to the tumor, with active tumor targeting being one of the most popular approaches. However, such an approach has been challenged by the intratumor heterogeneity and the lack of valid molecular target in many types of cancer. Here, we introduce a novel albumin-binding prodrug MPD02 that could specifically deliver highly potent cytotoxin monomethyl auristatin E (MMAE) to the tumor as an important component of chemoradiotherapy for the treatment of triple-negative breast cancer (TNBC). MPD02 was synthesized by conjugating MMAE to the C-terminus of the KGDEVD peptide via self-eliminating linker and introducing a maleimide group to the Lys side chain of the peptide. MPD02 was able to bind albumin after administration via maleimide group for an extended circulation time and metabolized into MMAE in tumor-specific manner by reacting with the caspase-3 upregulated in tumor by radiotherapy, exerting a highly potent anticancer effect with good safety profile in two different TNBC xenograft models.
Collapse
Affiliation(s)
- Seung Woo Chung
- Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, South Korea; Center for Nanomedicine, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, United States; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, United States
| | - Young Seok Cho
- Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergent Science and Technology, Seoul National University, Seoul 08826, Republic of Korea
| | - Jeong Uk Choi
- Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, South Korea
| | - Ha Rin Kim
- Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, South Korea
| | - Tae Hyung Won
- Boyce Thompson Institute and Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, United States
| | - Sang Yoon Kim
- Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
| | - Youngro Byun
- Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, South Korea; Center for Nanomedicine, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, United States.
| |
Collapse
|
4
|
cAMP-PKA-CaMKII signaling pathway is involved in aggravated cardiotoxicity during Fuzi and Beimu Combination Treatment of Experimental Pulmonary Hypertension. Sci Rep 2016; 6:34903. [PMID: 27739450 PMCID: PMC5064387 DOI: 10.1038/srep34903] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2016] [Accepted: 09/20/2016] [Indexed: 01/03/2023] Open
Abstract
Aconiti Lateralis Radix Praeparata (Fuzi) and Fritillariae Thunbergii bulbus (Beimu) have been widely used clinically to treat cardiopulmonary related diseases in China. However, according to the classic rules of traditional Chinese medicine, Fuzi and Beimu should be prohibited to use as a combination for their incompatibility. Therefore, it is critical to elucidate the paradox on the use of Fuzi and Beimu combination therapy. Monocrotaline-induced pulmonary hypertension rats were treated with either Fuzi, Beimu, or their combination at different stages of PH. We demonstrated that at the early stage of PH, Fuzi and Beimu combination significantly improved lung function and reduced pulmonary histopathology. However, as the disease progressed, when Fuzi and Beimu combination were used at the late stage of PH, right ventricular chamber dilation was histologically apparent and myocardial apoptosis was significantly increased compared with each drug alone. Western-blotting results indicated that the main chemical ingredient of Beimu could down-regulate the protein phosphorylation levels of Akt and PDE4D, whereas the combination of Fuzi and Beimu could up-regulate PKA and CaMKII signaling pathways. Therefore, we concluded that Fuzi and Beimu combination potentially aggravated the heart injury due to the inhibition of PDK1/Akt/PDE4D axis and subsequent synergistic activation of βAR-Gs-PKA/CaMKII signaling pathway.
Collapse
|
5
|
Ramasamy T, Poudel BK, Ruttala H, Choi JY, Hieu TD, Umadevi K, Youn YS, Choi HG, Yong CS, Kim JO. Cationic drug-based self-assembled polyelectrolyte complex micelles: Physicochemical, pharmacokinetic, and anticancer activity analysis. Colloids Surf B Biointerfaces 2016; 146:152-60. [DOI: 10.1016/j.colsurfb.2016.06.004] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2016] [Revised: 05/31/2016] [Accepted: 06/02/2016] [Indexed: 11/15/2022]
|
6
|
Chung SW, Choi JU, Lee BS, Byun J, Jeon OC, Kim SW, Kim IS, Kim SY, Byun Y. Albumin-binding caspase-cleavable prodrug that is selectively activated in radiation exposed local tumor. Biomaterials 2016; 94:1-8. [DOI: 10.1016/j.biomaterials.2016.03.043] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2016] [Revised: 03/11/2016] [Accepted: 03/28/2016] [Indexed: 10/22/2022]
|
7
|
Chung SW, Lee BS, Choi JU, Kim SW, Kim IS, Kim SY, Byun Y. Optimization of a Stable Linker Involved DEVD Peptide-Doxorubicin Conjugate That Is Activated upon Radiation-Induced Caspase-3-Mediated Apoptosis. J Med Chem 2015; 58:6435-47. [DOI: 10.1021/acs.jmedchem.5b00420] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Seung Woo Chung
- Research
Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, 151-742 Seoul, South Korea
| | - Beom Suk Lee
- Department
of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, 138-736 Seoul, South Korea
- Biomedical
Research Institute, Korea Institute of Science and Technology, 136-791 Seoul, South Korea
| | - Jeong uk Choi
- Research
Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, 151-742 Seoul, South Korea
| | - Seong Who Kim
- Department
of Biochemistry and Molecular Biology, Asan Medical Center, University of Ulsan College of Medicine, 138-736 Seoul, South Korea
| | - In-San Kim
- Biomedical
Research Institute, Korea Institute of Science and Technology, 136-791 Seoul, South Korea
| | - Sang Yoon Kim
- Department
of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, 138-736 Seoul, South Korea
- Biomedical
Research Institute, Korea Institute of Science and Technology, 136-791 Seoul, South Korea
| | - Youngro Byun
- Research
Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, 151-742 Seoul, South Korea
- Department
of Molecular Medicine and Biopharmaceutical Sciences, Graduate School
of Convergent Science and Technology, Seoul National University, 151-742 Seoul, South Korea
| |
Collapse
|
8
|
Bonifácio BV, Ramos MADS, da Silva PB, Negri KMS, de Oliveira Lopes É, de Souza LP, Vilegas W, Pavan FR, Chorilli M, Bauab TM. Nanostructured lipid system as a strategy to improve the anti-Candida albicans activity of Astronium sp. Int J Nanomedicine 2015; 10:5081-92. [PMID: 26300640 PMCID: PMC4536841 DOI: 10.2147/ijn.s79684] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
The genus Astronium (Anacardiaceae) includes species, such as Astronium fraxinifolium, Astronium graveolens, and Astronium urundeuva, which possess anti-inflammatory, anti-ulcerogenic, healing, and antimicrobial properties. Nanostructured lipid systems are able to potentiate the action of plant extracts, reducing the required dose and side effects and improving antimicrobial activity. This work aims to evaluate a nanostructured lipid system that was developed as a strategy to improve the anti-Candida albicans activity of hydroethanolic extracts of stems and leaves from Astronium sp. The antifungal activity against C. albicans (ATCC 18804) was evaluated in vitro by a microdilution technique. In addition to the in vitro assays, the Astronium sp. that showed the best antifungal activity and selectivity index was submitted to an in vivo assay using a model of vulvovaginal candidiasis infection. In these assays, the extracts were either used alone or were incorporated into the nanostructured lipid system (comprising 10% oil phase, 10% surfactant, and 80% aqueous phase). The results indicated a minimal inhibitory concentration of 125.00 µg/mL before incorporation into the nanostructured system; this activity was even more enhanced when this extract presented a minimal inhibitory concentration of 15.62 µg/mL after its incorporation. In vivo assay dates showed that the nanostructure-incorporated extract of A. urundeuva leaves was more effective than both the unincorporated extract and the antifungal positive control (amphotericin B). These results suggest that this nanostructured lipid system can be used in a strategy to improve the in vitro and in vivo anti-C. albicans activity of hydroethanolic extracts of Astronium sp.
Collapse
Affiliation(s)
- Bruna Vidal Bonifácio
- Department of Biological Sciences, School of Pharmaceutical Sciences, UNESP – Univ Estadual Paulista, Araraquara, São Paulo, Brazil
| | | | - Patrícia Bento da Silva
- Department of Drugs and Medicines, School of Pharmaceutical Sciences, UNESP – Univ Estadual Paulista, Araraquara, São Paulo, Brazil
| | - Kamila Maria Silveira Negri
- Department of Biological Sciences, School of Pharmaceutical Sciences, UNESP – Univ Estadual Paulista, Araraquara, São Paulo, Brazil
| | - Érica de Oliveira Lopes
- Department of Biological Sciences, School of Pharmaceutical Sciences, UNESP – Univ Estadual Paulista, Araraquara, São Paulo, Brazil
| | - Leonardo Perez de Souza
- Department of Organic Chemistry, Chemistry Institute, UNESP – Univ Estadual Paulista, Araraquara, São Paulo, Brazil
| | - Wagner Vilegas
- Coastal Campus of São Vicente, UNESP – Univ Estadual Paulista, São Vicente, São Paulo, Brazil
| | - Fernando Rogério Pavan
- Department of Biological Sciences, School of Pharmaceutical Sciences, UNESP – Univ Estadual Paulista, Araraquara, São Paulo, Brazil
| | - Marlus Chorilli
- Department of Drugs and Medicines, School of Pharmaceutical Sciences, UNESP – Univ Estadual Paulista, Araraquara, São Paulo, Brazil
| | - Taís Maria Bauab
- Department of Biological Sciences, School of Pharmaceutical Sciences, UNESP – Univ Estadual Paulista, Araraquara, São Paulo, Brazil
| |
Collapse
|
9
|
Kim YJ, Kim B, Hyun DC, Kim JW, Shim HE, Kang SW, Jeong U. Photocrosslinkable Poly(ε-caprolactone)-b
-Hyperbranched Polyglycerol (PCL-b
-hbPG) with Improved Biocompatibility and Stability for Drug Delivery. MACROMOL CHEM PHYS 2015. [DOI: 10.1002/macp.201500047] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Yong-Jin Kim
- Department of Materials Science and Engineering; Yonsei University; Seoul 120-749 South Korea
| | - Bongsoo Kim
- Department of Materials Science and Engineering; Yonsei University; Seoul 120-749 South Korea
| | - Dong Choon Hyun
- Department of Polymer Science and Engineering; Kyoungbook National University; Daegu 702-701 South Korea
| | - Jin Woong Kim
- Department of Applied Chemistry and Department of Bionano Technology; Hanyang University; Ansan 426-791 South Korea
| | - Hye-Eun Shim
- Next-Generation Pharmaceutical Research Center; Korea Institute of Toxicology; Daejeon 305-343 South Korea
| | - Sun-Woong Kang
- Next-Generation Pharmaceutical Research Center; Korea Institute of Toxicology; Daejeon 305-343 South Korea
- Human and Environmental Toxicology Program; University of Science and Technology; Daejeon South Korea
| | - Unyong Jeong
- Department of Materials Science and Engineering; Pohang University of Science and Technology (POSTECH); Pohang Gyeongbuk South Korea
| |
Collapse
|
10
|
Polypeptide-based Micelles for Delivery of Irinotecan: Physicochemical and In vivo Characterization. Pharm Res 2014; 32:1947-56. [PMID: 25471199 DOI: 10.1007/s11095-014-1588-8] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2014] [Accepted: 11/24/2014] [Indexed: 10/24/2022]
Abstract
PURPOSE Irinotecan (IRI) is a broad spectrum chemotherapeutic agent used individually or in combination to treat multiple malignancies. Present study aimed at developing polypeptide-based block ionomer complex (BIC) micelles to improve the pharmacokinetic and antitumor response of IRI. METHODS Irinotecan-loaded BIC micelles (IRI-BIC) was prepared and evaluated in terms of various physicochemical and biological parameters including size, shape, release, cytotoxicity, and pharmacokinetic analysis. In vivo antitumor efficacy was investigated in SCC-7 bearing xenograft tumor model. RESULTS IRI was successfully incorporated into the ionic cores of poly(ethylene glycol)-b-poly(aspartic acid) (PEG-b-PAA) with a high drug loading capacity (~80%). The electrostatically assembled BIC micelles were nanosized (~50 nm) with uniform size distribution pattern (PDI~0.1). The BIC micelles exhibited pH-sensitiveness with limited release of IRI at physiological conditions and significantly enhanced the release rate at acidic conditions, making it an ideal delivery system for tumor targeting. The IRI-BIC showed a dose-dependent cytotoxicity in SCC-7 and A-549 cancer cell lines. Pharmacokinetic studies clearly showed that BIC micelles improved the IRI blood circulation time and decreased its elimination rate constant, while that of free IRI, rapidly eliminated from the central compartment. Moreover, IRI-BIC showed superior therapeutic performance with no toxicity in BALB/c nude xenograft mice. The micelle treated group showed an inhibition rate of ~66% compared to free IRI treated group. CONCLUSIONS Taken together, BIC micelles could be a potentially useful nanovehicle with promising applicability in systemic tumor treatment.
Collapse
|
11
|
Candido CD, Campos ML, Correa Vidigal Assumpção JU, Pestana KC, Padilha EC, Carlos IZ, Peccinini RG. Biocompatible microemulsion modifies the tissue distribution of doxorubicin. J Pharm Sci 2014; 103:3297-301. [PMID: 25100266 DOI: 10.1002/jps.24106] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2014] [Revised: 06/24/2014] [Accepted: 07/08/2014] [Indexed: 11/08/2022]
Abstract
The incorporation of doxorubicin (DOX) in a microemulsion (DOX-ME) has shown beneficial consequences by reducing the cardiotoxic effects of DOX. The aim of this study was to determine the distribution of DOX-ME in Ehrlich solid tumor (EST) and the heart, and compare it with that of free DOX. The distribution study was conducted with female Swiss mice with EST (n = 7 per group; 20-25 g). Animals received a single dose (10 mg/kg, i.p.) of DOX or DOX-ME 7 days after tumor inoculation. Fifteen minutes after administration, the animals were sacrificed, and the tumor and heart tissues were taken for immediate analysis by ultra-performance liquid chromatography. No difference was observed in DOX concentration in tumor tissue between DOX and DOX-ME administration. However, the most remarkable result in this study was the statistically significant reduction in DOX concentration in heart tissue of animals given DOX-ME. Mean DOX concentration in heart tissue was 0.92 ± 0.54 ng mg(-1) for DOX-ME and 1.85 ± 0.34 ng mg(-1) for free DOX. In conclusion, DOX-ME provides a better tissue distribution profile, with a lower drug concentration in heart tissue but still comparable tumor drug concentration, which indicates that antitumor activity would not be compromised.
Collapse
Affiliation(s)
- Caroline Damico Candido
- Department of Natural Active Principles and Toxicology, School of Pharmaceutical Sciences, São Paulo State University - UNESP, Araraquara, 14801-902, SP, Brazil
| | | | | | | | | | | | | |
Collapse
|
12
|
Ramasamy T, Kim JH, Choi JY, Tran TH, Choi HG, Yong CS, Kim JO. pH sensitive polyelectrolyte complex micelles for highly effective combination chemotherapy. J Mater Chem B 2014; 2:6324-6333. [DOI: 10.1039/c4tb00867g] [Citation(s) in RCA: 68] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|
13
|
da Silva GBRF, Scarpa MV, Rossanezi G, do Egito EST, de Oliveira AG. Development and characterization of biocompatible isotropic and anisotropic oil-in-water colloidal dispersions as a new delivery system for methyl dihydrojasmonate antitumor drug. Int J Nanomedicine 2014; 9:867-76. [PMID: 24596463 PMCID: PMC3930478 DOI: 10.2147/ijn.s46055] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Microemulsions (MEs) are colloidal systems that can be used for drug-delivery and drug-targeting purposes. These systems are able to incorporate drugs modifying bioavailability and stability and reducing toxic effects. The jasmonate compounds belong to a group of plant stress hormones, and the jasmonic acid and its methyl ester derivative have been described as having anticancer activity. However, these compounds are very poorly water-soluble, not allowing administration by an intravenous route without an efficient nanostructured carrier system. In this work, biocompatible MEs of appropriate diameter size for intravenous route administration, loaded and unloaded with methyl dihydrojasmonate (MJ), were developed and described in a pseudo-ternary phase diagram. The compositions of the MEs were carefully selected from their own regions in the pseudo-ternary phase diagram. The formulations were analyzed by light scattering, polarized light microscopy, and X-ray diffraction. Also, a study on rheological profile was performed. The results showed that the droplet size decreased with both MJ incorporation and oil phase/surfactant ratio. All compositions of the studied MEs showed rheological behavior of pseudoplastic fluid and amorphous structures. In the absence of MJ, most of the studied MEs had thixotropic characteristics, which became antithixotropic in the presence of the drug. Almost all MJ-unloaded MEs presented anisotropic characteristics, but some formulations became isotropic, especially in the presence of MJ. The results of this study support the conclusion that the studied system represents a promising vehicle for in vivo administration of the MJ antitumor drug.
Collapse
Affiliation(s)
| | - Maria Virginia Scarpa
- Departamento de Fármacos e Medicamentos, Universidade Estadual Paulista (UNESP), Araraquara, SP, Brazil
| | - Gustavo Rossanezi
- Departamento de Fármacos e Medicamentos, Universidade Estadual Paulista (UNESP), Araraquara, SP, Brazil
| | | | - Anselmo Gomes de Oliveira
- Departamento de Fármacos e Medicamentos, Universidade Estadual Paulista (UNESP), Araraquara, SP, Brazil
| |
Collapse
|
14
|
Wu Z, Alany RG, Tawfeek N, Falconer J, Zhang W, Hassan IM, Rutland M, Svirskis D. A study of microemulsions as prolonged-release injectables through in-situ phase transition. J Control Release 2014; 174:188-94. [DOI: 10.1016/j.jconrel.2013.11.022] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2013] [Revised: 11/19/2013] [Accepted: 11/27/2013] [Indexed: 12/16/2022]
|
15
|
Dubey R. Controlled-release injectable microemulsions: recent advances and potential opportunities. Expert Opin Drug Deliv 2013; 11:159-73. [DOI: 10.1517/17425247.2014.870151] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|